Azenta Inc (AZTA)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $1.91B
Last updated: Nov 17, 2026 at 11:04 AM ET
Azenta Inc (AZTA) Earnings: Report Dates and Results
Azenta (AZTA) is expected to report earnings on Feb 2, 2027. In the quarter ended Sep 30, 2026, Azenta reported EPS of $0.28, above the $0.11 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
AZTA has an expected report date of Feb 2, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 11.1% below the $0.09 reported for the quarter ended Dec 31, 2025.
AZTA Earnings Call
The latest AZTA earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, AZTA beat 34, missed 5 and matched 1. The widest gap in the table came in the quarter ended Jun 30, 2023, when EPS landed 750.00% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.28 | $0.11 | $0.05 - $0.15 | +154.55% | Beat | +33.3% | 6 | 0 up, 2 down | Nov 10, 2026 | N/A |
| Jun 30, 2026 | $0.16 | $0.10 | $0.08 - $0.15 | +60.00% | Beat | -15.8% | 5 | 0 up, 4 down | Aug 4, 2026 | $161.18M |
| Mar 31, 2026 | -$0.04 | $0.14 | $0.11 - $0.20 | -128.57% | Miss | -180.0% | 5 | 0 up, 0 down | May 6, 2026 | $144.79M |
| Dec 31, 2025 | $0.09 | $0.13 | $0.11 - $0.18 | -30.77% | Miss | +12.5% | 7 | 0 up, 4 down | Feb 4, 2026 | $148.64M |
| Sep 30, 2025 | $0.21 | $0.20 | $0.18 - $0.23 | +5.00% | Beat | +16.7% | 7 | 0 up, 1 down | Nov 21, 2025 | $158.95M |
| Jun 30, 2025 | $0.19 | $0.14 | $0.10 - $0.17 | +35.71% | Beat | +18.8% | 6 | 2 up, 3 down | Aug 5, 2025 | $143.85M |
| Mar 31, 2025 | $0.05 | $0.07 | $0.02 - $0.09 | -28.57% | Miss | 0.0% | 6 | 0 up, 1 down | May 7, 2025 | $143.34M |
| Dec 31, 2024 | $0.08 | $0.06 | $0.01 - $0.11 | +33.33% | Beat | +300.0% | 6 | 0 up, 3 down | Feb 5, 2025 | $147.44M |
| Sep 30, 2024 | $0.18 | $0.11 | $0.05 - $0.13 | +63.64% | Beat | +38.5% | 7 | 0 up, 0 down | Nov 12, 2024 | $151.08M |
| Jun 30, 2024 | $0.16 | $0.07 | $0.03 - $0.11 | +128.57% | Beat | +23.1% | 7 | 0 up, 0 down | Aug 6, 2024 | $144.29M |
| Mar 31, 2024 | $0.05 | $0.02 | $0.01 - $0.03 | +150.00% | Beat | N/A | 6 | 0 up, 0 down | May 8, 2024 | $136.35M |
| Dec 31, 2023 | $0.02 | -$0.03 | -$0.05 - -$0.01 | +166.67% | Beat | -83.3% | 5 | 0 up, 0 down | Feb 7, 2024 | $141.72M |
| Sep 30, 2023 | $0.13 | $0.02 | $0.00 - $0.03 | +550.00% | Beat | -18.8% | 6 | 1 up, 0 down | Nov 13, 2023 | $58.77M |
| Jun 30, 2023 | $0.13 | -$0.02 | -$0.07 - $0.02 | +750.00% | Beat | +8.3% | 6 | 0 up, 1 down | Aug 8, 2023 | $165.95M |
| Mar 31, 2023 | -$0.06 | -$0.02 | -$0.06 - $0.02 | -200.00% | Miss | -150.0% | 5 | 0 up, 0 down | May 9, 2023 | $148.40M |
| Dec 31, 2022 | $0.12 | $0.10 | $0.01 - $0.12 | +20.00% | Beat | 0.0% | 4 | 0 up, 0 down | Feb 8, 2023 | $178.37M |
| Sep 30, 2022 | $0.16 | $0.07 | $0.04 - $0.12 | +128.57% | Beat | -79.5% | 5 | 0 up, 0 down | Nov 14, 2022 | $137.57M |
| Jun 30, 2022 | $0.12 | $0.09 | $0.08 - $0.12 | +33.33% | Beat | -83.3% | 5 | 1 up, 1 down | Aug 9, 2022 | $132.74M |
| Mar 31, 2022 | $0.12 | $0.11 | $0.10 - $0.12 | +9.09% | Beat | -80.3% | 5 | 0 up, 0 down | May 9, 2022 | $145.54M |
| Dec 31, 2021 | $0.12 | $0.08 | $0.06 - $0.09 | +50.00% | Beat | -74.5% | 5 | 0 up, 0 down | Feb 8, 2022 | $139.65M |
| Sep 30, 2021 | $0.78 | $0.77 | N/A | +1.30% | Beat | +66.0% | N/A | N/A | Nov 10, 2021 | $136.94M |
| Jun 30, 2021 | $0.72 | $0.69 | N/A | +4.35% | Beat | +125.0% | N/A | N/A | Aug 5, 2021 | $129.09M |
| Mar 31, 2021 | $0.61 | $0.51 | N/A | +19.61% | Beat | +144.0% | N/A | N/A | May 10, 2021 | $129.53M |
| Dec 31, 2020 | $0.47 | $0.42 | N/A | +11.90% | Beat | +104.3% | N/A | N/A | Feb 2, 2021 | $118.14M |
| Sep 30, 2020 | $0.47 | $0.36 | N/A | +30.56% | Beat | +95.8% | N/A | N/A | Nov 10, 2020 | N/A |
| Jun 30, 2020 | $0.32 | $0.20 | N/A | +60.00% | Beat | +60.0% | N/A | N/A | Jul 30, 2020 | $220.35M |
| Mar 31, 2020 | $0.25 | $0.25 | N/A | 0.00% | In line | +47.1% | N/A | N/A | Apr 30, 2020 | $220.23M |
| Dec 31, 2019 | $0.23 | $0.24 | N/A | -4.17% | Miss | +35.3% | N/A | N/A | Feb 6, 2020 | $210.50M |
| Sep 30, 2019 | $0.24 | $0.23 | N/A | +4.35% | Beat | -40.0% | N/A | N/A | Nov 6, 2019 | N/A |
| Jun 30, 2019 | $0.20 | $0.16 | N/A | +25.00% | Beat | -56.5% | N/A | N/A | Aug 1, 2019 | $203.88M |
| Mar 31, 2019 | $0.17 | $0.10 | N/A | +70.00% | Beat | -57.5% | N/A | N/A | Apr 29, 2019 | $198.39M |
| Dec 31, 2018 | $0.17 | $0.13 | N/A | +30.77% | Beat | -46.9% | N/A | N/A | Feb 5, 2019 | $179.37M |
| Sep 30, 2018 | $0.40 | $0.38 | N/A | +5.26% | Beat | +14.3% | N/A | N/A | Nov 19, 2018 | $159.65M |
| Jun 30, 2018 | $0.46 | $0.43 | N/A | +6.98% | Beat | +27.8% | N/A | N/A | Aug 6, 2018 | $172.36M |
| Mar 31, 2018 | $0.40 | $0.36 | N/A | +11.11% | Beat | +42.9% | N/A | N/A | May 1, 2018 | $156.95M |
| Dec 31, 2017 | $0.32 | $0.29 | N/A | +10.34% | Beat | +28.0% | N/A | N/A | Feb 1, 2018 | $142.60M |
| Sep 30, 2017 | $0.35 | $0.29 | N/A | +20.69% | Beat | +59.1% | N/A | N/A | Nov 9, 2017 | $16.49M |
| Jun 30, 2017 | $0.36 | $0.30 | N/A | +20.00% | Beat | +125.0% | N/A | N/A | Aug 2, 2017 | $181.72M |
| Mar 31, 2017 | $0.28 | $0.25 | N/A | +12.00% | Beat | +300.0% | N/A | N/A | Apr 27, 2017 | $169.33M |
| Dec 31, 2016 | $0.25 | $0.20 | N/A | +25.00% | Beat | +1150.0% | N/A | N/A | Feb 1, 2017 | $159.96M |
Annual EPS
EPS for the fiscal year ended Sep 30, 2026 was $0.49, within 4 cents of the year before. It was $1.24 for the year ended Sep 30, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Sep 30, 2026 | $0.49 | N/A |
| Sep 30, 2025 | $0.53 | +29.3% |
| Sep 30, 2024 | $0.41 | +28.1% |
| Sep 30, 2023 | $0.32 | -38.5% |
| Sep 30, 2022 | $0.52 | -79.8% |
| Sep 30, 2021 | $2.58 | +103.1% |
| Sep 30, 2020 | $1.27 | +62.8% |
| Sep 30, 2019 | $0.78 | -50.6% |
| Sep 30, 2018 | $1.58 | +27.4% |
| Sep 30, 2017 | $1.24 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,900 words across 10 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 6,925 | 10 | |
| 2026Q2 | Jun 30, 2026 | 8,518 | 10 | |
| 2026Q1 | Mar 31, 2026 | 7,803 | 11 | |
| 2025Q4 | Dec 31, 2025 | 6,928 | 10 | |
| 2025Q3 | Sep 30, 2025 | 5,189 | 11 | |
| 2025Q2 | Jun 30, 2025 | 6,742 | 9 | |
| 2025Q1 | Mar 31, 2025 | 7,111 | 10 | |
| 2024Q4 | Dec 31, 2024 | 7,538 | 10 |
2026Q3 Earnings Call
Opening remarks
Yvonne Perron Vice President, FP&A and Investor Relations Thank you, operator, and good morning, and welcome to everyone joining us today. We would like to welcome you to our earnings conference call for the third quarter of fiscal year 2026. Our third quarter earnings press release was issued yesterday after market and is available on our Investor Relations website located at investors.azenta.com in addition to the PowerPoint slides and the supplementary information that will be used during the prepared remarks today. Please note that effective the first fiscal quarter of 2025, the results of B Medical Systems are treated as discontinued operations. The previously disclosed sale of the B Medical Systems business was completed on July 1, 2026. I would like to remind everyone that during the course of the call, we will be making a number of forward-looking statements within the meaning of the Private Litigation Securities Act of 1995. There are many factors that may cause actual financial results or other events to differ from those identified in such forward-looking statements. I would refer you to the section of our earnings release titled Safe Harbor Statement, the safe harbor slide on the aforementioned PowerPoint presentation on our website and our various filings with the SEC, including our annual reports on Form 10-K and our quarterly reports on Form 10-Q. We make no obligation to update these statements should future financial data or events occur that differ from the forward-looking statements presented today. We may refer to a number of non-GAAP financial measures, which are used in addition to and in conjunction with results presented in accordance with GAAP. We believe the non-GAAP measures provide an additional way of viewing aspects of our operations and performance, but when considered with GAAP financial results and the reconciliation of GAAP measures, they provide an even more complete understanding of the Azenta business. Non-GAAP measures should not be relied upon to the exclusion of the GAAP measures themselves. On the call with me today is our President and Chief Executive Officer, John Marotta; and our Executive Vice President and Chief Financial Officer, Lawrence Lin. We will begin the call with opening remarks from John, followed by Lawrence, who will provide a detailed review of our financial results and our outlook for fiscal year 2026. We will then take your questions at the end of the prepared remarks. With that, I would like to turn the call over to our CEO, John Marotta.
John P. Marotta President and Chief Executive Officer Good morning, everyone, and thank you for joining us today. In the third quarter, despite an uneven and challenging market, we made substantial progress delivering against our commitments towards rebuilding confidence through performance. Revenue exceeded our outlook, profitability improved sequentially and Multiomics delivered year-over-year growth.
Frequently Asked Questions About AZTA
When is Azenta's next earnings date?
Azenta's next earnings report is expected for Feb 2, 2027.
Did AZTA beat earnings estimates last quarter?
Yes. Azenta reported EPS of $0.28 for the quarter ended Sep 30, 2026, above the $0.11 estimate, a 154.55% surprise.
What EPS do analysts expect from AZTA next quarter?
The consensus EPS estimate for Azenta for the quarter ending Dec 31, 2026 is $0.08 from 2 analysts, with estimates from $0.06 to $0.09.
How often does AZTA beat earnings estimates?
Azenta beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +12.59%.
AZTA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts